Weight-Loss Drugs Like Ozempic Spur Major Bank’s Recommendation to Short Junk Food Stocks
Is the Rise of Weight-Loss Drugs Like Ozempic a Threat to Junk Food Stocks? The investment banking world is abuzz with a new recommendation that’s as intriguing as it is controversial. A major bank has recently advised investors to short junk food stocks, citing the promising rise of weight-loss drugs like Ozempic. But what does …